Hercules Pharmaceuticals today announced the appointment of Ali Ahmed as Executive Vice President, Chief Commercial Officer.

First and only transgenic chicken platform engineered to express ultralong CDRH3 domains on a human antibody framework ...

John Johnson, current board member, appointed to chairman of the boardMichael Kauffman, M.D., Ph.D., lead director since 2016, appointed to president of developmentCommercial launch progresses as RAMP ...

Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an ...

WASHINGTON, D.C. / ACCESS Newswire / December 15, 2025 / Leading national organizations have come together to form the Alliance to Strengthen America's Health Workforce for the Underserved, a ...

The program is designed with a novel, liver-detargeting, muscle-tropic capsid intended to improve safety and ...

The "Botulinum Toxin in Urology Market Outlook 2026-2034: Market Share and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Botulinum Toxin in Urology Market is valued at USD 1 ...

OrganaBio, LLC, a leading provider of human research- and clinical-grade cellular starting materials and clinical trial support services today announced the opening of its newest cell processing and ...

The "Tourette Syndrome Drugs Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering.The Tourette Syndrome Drugs Market is projected to witness ...

OlivePoint Capital (“OlivePoint”), an institutional real estate investment manager focused on thematic and special situations strategies, and Redwood Capital Management, LLC, a global alternative ...

ATHEN, Griechenland--(BUSINESS WIRE)-- BEKANNTMACHUNG NUR FÜR EUROPÄISCHE MEDIZIN- UND PHARMAZEUTISCHE FACHMEDIEN SOWIE EUROPÄISCHE FINANZMEDIEN GENESIS Pharma, ein regionales Biopharmaunternehmen, da ...

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...